SCHEMBL17268610

SCHEMBL17268610

CC(C)OC(=O)C(Cc1cc(=O)[nH]c2ccccc12)NC(=O)c1ccc(Cl)cc1

nearest known ligand 0.75

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ UBASH3B Q8TF42 1/20 0.75
▸ TACR1 P25103 6/20 0.52
▸ KDM4E B2RXH2 2/20 0.49
▸ ALDH1A1 P00352 2/20 0.49
▸ PKM P14618 1/20 0.49
▸ F11 P03951 2/20 0.48
▸ CCKBR P32239 1/20 0.47
▸ HPGD P15428 1/20 0.46
▸ HSD17B10 Q99714 1/20 0.46
▸ PPARG P37231 1/20 0.45
▸ MEN1 O00255 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ LMNA P02545 1/20 0.44
▸ TP53 P04637 1/20 0.44
▸ MAPT P10636 1/20 0.44
▸ THRB P10828 1/20 0.44
▸ PTGS2 P35354 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16666855 0.91 UBASH3B (0.79) UBASH3BTACR1KDM4EALDH1A1PKM
SCHEMBL16666555 0.89 UBASH3B (0.76) UBASH3BTACR1KDM4EALDH1A1PKM
SCHEMBL16666339 0.89 UBASH3B (0.68) UBASH3BTACR1KDM4EALDH1A1PKM
SCHEMBL16666556 0.88 UBASH3B (0.71) UBASH3BTACR1KDM4EALDH1A1PKM
SCHEMBL16666447 0.88 UBASH3B (0.68) UBASH3BTACR1KDM4EALDH1A1PKM
SCHEMBL16666648 0.88 UBASH3B (0.74) UBASH3BTACR1KDM4EALDH1A1PKM
SCHEMBL16666489 0.88 UBASH3B (0.74) UBASH3BTACR1KDM4EALDH1A1PKM
SCHEMBL16666451 0.88 UBASH3B (0.74) UBASH3BTACR1KDM4EALDH1A1PKM
SCHEMBL3420093 0.87 UBASH3B (0.70) UBASH3BTACR1KDM4EALDH1A1PKM
SCHEMBL9294082 0.87 UBASH3B (0.72) UBASH3BTACR1KDM4EALDH1A1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180125986-A1 Nitric Oxide Releasing Produgs of Therapeutic Agents SATYAM APPARAO (IN) 2018-05-10 — — US disclosed
US-9844599-B2 Nitric oxide releasing produgs of therapeutic agents SATYAM APPARAO (IN) 2017-12-19 — — US disclosed
US-20150328323-A1 Nitric Oxide Releasing Produgs of Therapeutic Agents SATYAM APPARAO (IN) 2015-11-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180125986-A1 Nitric Oxide Releasing Produgs of Therapeutic Agents NOS2, NOS1, NOS3 UBASH3B 4529/4885TACR1 249/4885KDM4E 3441/4885
US-20150328323-A1 Nitric Oxide Releasing Produgs of Therapeutic Agents NOS2, NOS1, PTGIS UBASH3B 4502/4885TACR1 269/4885KDM4E 3686/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback